Abstract
Despite considerable advances in the treatment of cardiovascular disease, it remains the leading cause of death in developed countries. Assessment of classic cardiovascular risk factors — including high blood pressure, diabetes and smoking — has a central role in disease prevention. However, many individuals with coronary heart disease (a narrowing of the blood vessels that supply the heart) have only one, or none, of the classic risk factors. Thus, new biomarkers are needed to augment the information obtained from traditional indicators and to illuminate disease mechanisms.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fnature06802/MediaObjects/41586_2008_Article_BFnature06802_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fnature06802/MediaObjects/41586_2008_Article_BFnature06802_Fig2_HTML.jpg)
Similar content being viewed by others
References
Wilson, P. W. CDC/AHA workshop on markers of inflammation and cardiovascular disease: Application to clinical and public health practice: Ability of inflammatory markers to predict disease in asymptomatic patients: a background paper. Circulation 110, e568–e571 (2004).
Wang, T. J. et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N. Engl. J. Med. 355, 2631–2639 (2006).
Ware, J. H. The limitations of risk factors as prognostic tools. N. Engl. J. Med. 355, 2615–2617 (2006).
Pepe, M. S. & Thompson, M. L. Combining diagnostic test results to increase accuracy. Biostatistics 1, 123–140 (2000).
Hirschhorn, J. N., Lohmueller, K., Byrne, E. & Hirschhorn, K. A comprehensive review of genetic association studies. Genet. Med. 4, 45–61 (2002).
Samani, N. J. et al. Genomewide association analysis of coronary artery disease. N. Engl. J. Med. 357, 443–453 (2007).
McPherson, R. et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316, 1488–1491 (2007).
Helgadottir, A. et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316, 1491–1493 (2007).
Tachibana, K. et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393, 591–594 (1998).
Peled, A. et al. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34+ cells on vascular endothelium under shear flow. J. Clin. Invest. 104, 1199–1211 (1999).
Abi-Younes, S. et al. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ. Res. 86, 131–138 (2000).
Timpson, N. J. et al. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet 366, 1954–1959 (2005).
Wald, D. S., Law, M. & Morris, J. K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. B. Med. J. 325, 1202 (2002).
Weinberg, E. O. et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 106, 2961–2966 (2002).
Healy, A. M. et al. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 113, 2278–2284 (2006).
Weinberg, E. O. et al. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 107, 721–726 (2003).
Shimpo, M. et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 109, 2186–2190 (2004).
Anderson, N. L. et al. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol. Cell. Proteomics 3, 311–326 (2004).
Omenn, G. S. et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5, 3226–3245 (2005).
Wishart, D. S. et al. HMDB: the Human Metabolome Database. Nucleic Acids Res. 35, D521–D526 (2007).
Roe, C. R., Millington, D. S. & Maltby, D. A. Identification of 3-methylglutarylcarnitine. A new diagnostic metabolite of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency. J. Clin. Invest. 77, 1391–1394 (1986).
Frazier, D. M. et al. The tandem mass spectrometry newborn screening experience in North Carolina: 1997–2005. J. Inherit. Metab. Dis. 29, 76–85 (2006).
Brindle, J. T. et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nature Med. 8, 1439–1444 (2002).
Nielsen, E.-M. D. et al. The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 52, 573–577 (2003).
Kirschenlohr, H. L. et al. Proton NMR analysis of plasma is a weak predictor of coronary artery disease. Nature Med. 12, 705–710 (2006).
Sabatine, M. S. et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112, 3868–3875 (2005).
Acknowledgements
The authors are grateful for support from the National Institutes of Health (to R.E.G. and T.J.W.), the Donald W. Reynolds Foundation (to R.E.G.), the Fondation Leducq (to R.E.G.) and the American Heart Association (to T.J.W.).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Additional information
Correspondence should be addressed to R.E.G. (rgerszten@partners.org).
Rights and permissions
About this article
Cite this article
Gerszten, R., Wang, T. The search for new cardiovascular biomarkers. Nature 451, 949–952 (2008). https://doi.org/10.1038/nature06802
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature06802
This article is cited by
-
Plasma metabolomics and quantitative interstitial abnormalities in ever-smokers
Respiratory Research (2023)
-
Identification of hub genes and their expression profiling for predicting buffalo (Bubalus bubalis) semen quality and fertility
Scientific Reports (2023)
-
Untargeted metabolic analysis in dried blood spots reveals metabolic signature in 22q11.2 deletion syndrome
Translational Psychiatry (2022)
-
Application of Metabolomics in Childhood Leukemia Diagnostics
Archivum Immunologiae et Therapiae Experimentalis (2022)
-
Whole Genome Association Study of the Plasma Metabolome Identifies Metabolites Linked to Cardiometabolic Disease in Black Individuals
Nature Communications (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.